Emergent BioSolutions Inc. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Emergent BioSolutions Inc. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 27.06 | 1,077 | 29,144 | 35,068 | 36.1 K to 35.1 K (-2.98 %) |
| Mar 18 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 27.06 | 2,248 | 60,831 | 155,533 | 157.8 K to 155.5 K (-1.42 %) |
| Mar 14 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 27.06 | 3,659 | 99,013 | 2,141,275 | 2.1 M to 2.1 M (-0.17 %) |
| Mar 14 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 27.15 | 1,463 | 39,720 | 2,144,934 | 2.1 M to 2.1 M (-0.07 %) |
| Mar 13 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 27.15 | 3,021 | 82,020 | 157,781 | 160.8 K to 157.8 K (-1.88 %) |
| Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 18.90 | 11,562 | 218,522 | 0 | |
| Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 27.50 | 11,562 | 317,955 | 36,145 | 47.7 K to 36.1 K (-24.24 %) |
| Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 18.90 | 11,562 | 218,522 | 47,707 | 36.1 K to 47.7 K (+31.99 %) |
| Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 27.15 | 775 | 21,041 | 36,145 | 36.9 K to 36.1 K (-2.10 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 28.09 | 112,479 | 3,159,535 | 112,479 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 28.09 | 1,887 | 53,006 | 2,144,510 | 2.1 M to 2.1 M (-0.09 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Grant | A | 0.00 | 56,240 | 0 | 2,146,397 | 2.1 M to 2.1 M (+2.69 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | A | 28.09 | 28,119 | 789,863 | 28,119 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Grant | A | 28.09 | 14,060 | 394,945 | 29,202 | 15.1 K to 29.2 K (+92.85 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | A | 28.09 | 123,192 | 3,460,463 | 123,192 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Grant | A | 0.00 | 61,596 | 0 | 160,802 | 99.2 K to 160.8 K (+62.09 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 28.09 | 4,347 | 122,107 | 99,206 | 103.6 K to 99.2 K (-4.20 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Option Exercise | A | 28.09 | 52,062 | 1,462,422 | 52,062 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Grant | A | 0.00 | 26,031 | 0 | 112,372 | 86.3 K to 112.4 K (+30.15 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 15.83 | 4,887 | 77,361 | 4,887 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 15.91 | 6,933 | 110,304 | 0 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | A | 28.09 | 28,119 | 789,863 | 28,119 | |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 26.96 | 11,820 | 318,667 | 36,920 | 48.7 K to 36.9 K (-24.25 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 15.91 | 6,933 | 110,304 | 48,800 | 41.9 K to 48.8 K (+16.56 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 15.83 | 4,887 | 77,361 | 41,807 | 36.9 K to 41.8 K (+13.24 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 26.96 | 5,835 | 157,312 | 36,920 | 42.8 K to 36.9 K (-13.65 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 14,060 | 0 | 42,755 | 28.7 K to 42.8 K (+49.00 %) |
| Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 28.09 | 1,336 | 37,528 | 28,695 | 30 K to 28.7 K (-4.45 %) |